Kangmei Pharma | 600518 - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
Avita Medical AUD 19.03M 1.95M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Genomma Lab Internacional MXN 1.7B 114.59M 2026-03
Hypermarcas BRL 554.5M 201.69M 2026-03
Ionis Pharmaceuticals USD 151M 21M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Jiangsu Hengrui CNY 2.81B 191.05M 2026-03
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Moderna USD 173M 135M 2026-03
Organon & Co USD 424M 9M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Sh Fosun Pharma CNY 3.27B 1.17B 2026-03
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Viatris USD 928.8M 101.9M 2026-03
Wuxi Apptec CNY 891.8M 147.89M 2026-03
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03